Ziranu, P., Demurtas, L., Puzzoni, M., Loupakis, F., Daniele, B., Rimassa, L., Bilancia, D., Lonardi, S., Avallone, A., Pella, N., Ferrari, D., Frassineti, L., Beretta, G., Zaniboni, A., Santoro, A., Zampino, M., Sarobba, M., Zagonel, V., Barni, S., Palmieri, G., Labianca, R., Cascinu, S., & Scartozzi, M. (n.d.). p-291The DISTINCTIVE study: A biologically enriched phase II study of seconD-line folfiri/aflIbercept in proSpecTIvely stratified, anti-EGFR resistaNt, metastatic coloreCTal cancer patIents with RAS Validated wild typE status - Trial in progress. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095320550.0x000032